Asuragen Receives Certification for Gene Expression Profiling

Illumina, Inc. (San Diego, CA, USA) and Asuragen, Inc. (Austin Texas, USA) have announced that Asuragen has successfully completed Illumina Certified Service Provider (CSPro) certification for gene expression profiling.

Asuragen is the first commercial service provider to offer Illumina gene expression profiling services. Illumina provides next-generation tools for the large-scale analysis of genetic variation and function.

"In response to customer requests, we are pleased to offer an additional choice in gene expression profiling with the Illumina platform,” said Rollie Carlson, President of Asuragen. "The work performed by Asuragen and Illumina to demonstrate proficiency in the CSPro program will assure customers quality data.”

Combined with Asuragen's sample preparation, scientists can perform gene expression profiling from low amounts of starting sample, including those traditionally used in clinical settings, such as biopsies, fine needle aspirates, etc. Data from the Illumina platform are compatible with Asuragen's Standard Service Premium and Pathways Analysis Services.

"Our commitment to quality and innovative technologies is what inspired us to become an Illumina CSPro. The Illumina platform allows us to provide solutions to the experimental needs of our customers,” said Scott Hunicke-Smith, vice president and general manager of Asuragen Services.

"Recent results from the MicroArray Quality Control project confirmed that Illumina's gene expression technology is capable of generating excellent quality and performance, and boosting the number of detected genes,” he continued.


Related Links:
Illumina
Asuragen